Animal Health Partnering Interests | Boehringer Ingelheim CA
Partnering for innovation in animal health
We’re focused on discovering and developing breakthroughs that tackle the most important scientific challenges we face. So we’re looking for visionary partners in both animal health and human pharma, who bring valuable new ideas and science to our collective innovation journey. This broad perspective is key to accelerating the next wave of therapeutics that will transform animal health now and in generations to come.
Our animal health partnering interests
Infectious diseases
Bacterial diseases
Viral diseases
Parasitic diseases
Parasitic diseases
Non-infectious diseases
Cardio-renal-metabolic diseases & obesity
Central nervous system diseases
Immunology & inflammation
Oncology
Oral Health
Pain & Mobility
Non-disease specific
Technologies
Digital Science
Our partnering activities include:
- Focusing on the discovery and development of innovative solutions in our scientific areas of focus
- Pursuing novel technologies to support therapeutic advances in key areas of unmet need
- Connecting across the wider scientific community to translate learnings into breakthroughs that could improve the lives of animals
We’re interested in therapeutic solutions and technologies across several areas of animal health: bacterial, viral, and parasitic diseases, as well as non-infectious issues, including cardio-renal-metabolic diseases and obesity; central nervous system diseases; immunology and inflammation; oncology; oral health; and pain and mobility.
Infectious diseases
Building on Boehringer Ingelheim’s longstanding leadership in preventive animal health care, we’re interested in collaborations that advance the next generation of vaccines and treatments for Bacterial diseases (PDF), Viral diseases (PDF), and Parasitic diseases (PDF). To see our partnering interests in these areas, please click on the links above. We’re open to a variety of partnership models to explore:
- Bacterial and viral diseases in food animal production
- Bacterial and viral diseases affecting pets
- Transboundary and emerging diseases across all species
- Novel adjuvant systems and platforms for animal health
- Prevention and treatment of ecto- and endo-parasites across all species
- Sustainable and green chemistry technologies in anti-parasitics
Connect with our team
Contact our Partnering team in infectious diseases:
| Email Veljko Nikolin Bacterial & viral diseases |
| Email Sandra Noack Parasitic diseases |
We aim to respond to you within seven business days. Please note that this email address is not intended for adverse event reporting. If you need to report an adverse event, please contact Veterinary Product Adverse Events.
Non-infectious diseases
We’re actively pursuing partnerships to help address unmet needs in many non-infectious diseases that have an impact on the quality of life or the lifespan of dogs, cats, and horses. To see our partnering interests in these areas, please click on the links below.
- Cardio-renal-metabolic diseases (PDF) and obesity in cats and dogs
- Central nervous system (CNS) disorders (PDF), such as anxiety and cognitive dysfunction, in pets and horses
- Inflammatory and immunology conditions (PDF), such as osteoarthritis, dermatitis and inflammatory bowel disease
- Canine and feline oncology (PDF), exploring both cell-directed and immune pathways
- Pet oral health (PDF), such as periodontitis, especially solutions for easier administration
- Pain and mobility (PDF) issues in pets and horses, including osteoarthritis and post-surgical pain
Connect with our team
Contact our Partnering team in non-infectious diseases:
| Email Hervé Poulet Non-infectious diseases |
We aim to respond to you within seven business days. Please note that this email address is not intended for adverse event reporting. If you need to report an adverse event, please contact Veterinary Product Adverse Events.
Non-disease specific
Beyond the molecules and compounds that prevent and treat animal disease, we’re interested in advancing cutting-edge Technologies (PDF) and Digital Science (PDF) applications that can impact many areas of animal health. To see our partnering interests in these areas, please click on the links above. Contact us to discuss collaborating on:
- Novel or long-acting pharmaceutical delivery mechanisms that enhance ease or convenience
- Manufacturing technologies, at any stage of the process
- Innovative biotherapeutic platforms
- Communication solutions for vets and animal owners
- Data management platforms
- Digital diagnostic and monitoring tools
Connect with our team
Contact our Partnering team in technologies and digital science:
| Email Sandra Noack Technologies & Digital Science |
Partnering priorities for 2026
This year, we're focusing on partnering opportunities in oncology, oral health and central nervous system diseases. We're also seeking later-stage collaborations to complement our internal portfolio in infectious diseases, cardiovascular, renal and skin diseases and obesity.
“We truly believe that listening to and learning from each other can accelerate innovation in animal health. New ideas and new science bring critical diversity of thought and could spark the next transformative solution. Let’s work together to begin new innovation journeys and co-create the next breakthrough that could build a healthier future for animals.”
Megan Grether
Global Head of Business Development and Licensing, Animal Health
Connect with us
We’re excited to hear your ideas. Connect with our Animal Health Partnering team by email, through our online portal, or at an industry event.